实验室步速与日常生活步速同衰弱、肌少症及生活空间移动性的关联
该横断面研究纳入1025名社区中老年人(平均63岁),比较实验室步速(LGS)与日常生活步速(DGS)对衰弱前期/衰弱、可能肌少症及生活空间移动性受限(RLSM)的判别能力。结果显示LGS与DGS仅弱相关,LGS的AUC(0.63-0.74)高于DGS(0.59-0.73),且在LGS基础上加入DGS未显著提高判别能力。结论提示在功能一般良好的社区成人中,单用LGS即可实现足够的风险分层。
要点
- LGS与DGS仅弱相关(Spearman rho=0.22),两者不可互换。
- LGS对衰弱、肌少症及RLSM的AUC为0.63-0.74,高于DGS的0.59-0.73。
- 在LGS基础上加入DGS未显著提高对所有结局的判别能力。
核心结论
- 在功能一般良好的社区中老年人中,LGS与DGS不可互换,但单用LGS即可对衰弱前期/衰弱、可能肌少症及RLSM达到足够的判别准确度。
- 常规实验室步速评估可能足以用于社区成人的风险分层。
研究设计与样本
- 横断面研究,纳入1025名社区中老年人,平均年龄63岁(SD 7.3)。
- LGS采用10米步速测试;DGS由14天旅行日记中步行 trips 经地理空间追踪手机应用计算平均步速。
主要发现
- LGS与DGS弱相关(Spearman rho=0.22),两者差异(均值±2 SD)为0.33±0.48 m/s。
- LGS对各结局的AUC为0.63-0.74,DGS的AUC为0.59-0.73。
- 在LGS基础上加入DGS未显著提高所有结局的AUC(差值0.00-0.01;P值0.15-0.70)。
关键数值与推荐
- FRAIL评分≥1判定为衰弱前期/衰弱。
- 握力弱(女性<18 kg,男性<28 kg)判定为可能肌少症。
- 生活空间评估<60分判定为生活空间移动性受限(RLSM)。
临床怎么用
- 在社区中老年人风险分层中,可优先采用10米实验室步速测试,无需常规依赖日常生活步速监测。
- 若已具备LGS评估条件,额外采集DGS对判别衰弱、肌少症及RLSM的增益有限。
局限性
- 横断面设计无法推断因果关系。
- 样本为功能一般良好的社区中老年人,结论外推至功能较差或衰弱人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although daily-life gait speed (DGS) may better reflect real-world walking than laboratory- or clinic-based gait speed (LGS), it is unclear whether DGS provides superior discriminatory value for clinical outcomes. We compared LGS and DGS on their discriminative abilities concerning the risk of prefrailty/frailty, probable sarcopenia, and restricted life-space mobility (RLSM) in community-dwelling middle-aged and older adults. DESIGN: Cross-sectional study. SETTING AND PARTICIPANTS: A sample of 1025 participants (mean [SD], 63 [7.3]years) completed a survey and fitness assessment, from which LGS, DGS, FRAIL (fatigue, resistance, ambulation, illness, and loss of weight) score, handgrip strength, and life-space assessment were measured. METHODS: LGS was measured by the 10-m gait speed test and average DGS was computed from walking trips recorded in a 14-day travel diary on a geospatial tracking mobile application. Participants with a FRAIL score ≥1, a weak handgrip strength (<18 kg for women and <28 kg for men), and a life-space assessment <60 points were classified as having prefrailty/frailty, probable sarcopenia, and RLSM, respectively. RESULTS: LGS and DGS were weakly correlated (Spearman rho = 0.22), and their difference (mean ±2 SD) was 0.33 ± 0.48 m/s. Across outcomes, LGS showed higher areas under the curve (AUCs) (0.63 to 0.74) than did DGS (AUCs, 0.59 to 0.73). Adding DGS to LGS did not significantly increase the AUCs for the discrimination of all outcomes (differences in AUCs, 0.00 to 0.01; P values, 0.15 to 0.70). CONCLUSIONS AND IMPLICATIONS: In a sample of generally well-functioning adults, although LGS and DGS were not interchangeable, sufficient discrimination accuracy for the prefrailty/frailty, probable sarcopenia, and RLSM outcomes could be achieved with LGS alone. These findings suggest that routine laboratory gait speed assessment may be sufficient for risk stratification in community-dwelling adults.
引用
- Pua YH, Lin S, Tan JM, et al. Associations of Laboratory-Based Gait Speed and Daily-Life Gait Speed With Frailty, Sarcopenia, and Life-Space Mobility in Community-Dwelling Older Adults. J Am Med Dir Assoc. 2026. PMID: 41314620. doi:10.1016/j.jamda.2025.106014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。